| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 7.780 | 13.058 | 29.440 | 110.956 | 227.372 | 338.758 | 413.028 | 466.433 | 574.885 |
| Total Income - EUR | - | 7.780 | 13.058 | 29.440 | 110.956 | 228.519 | 343.186 | 420.332 | 481.241 | 595.986 |
| Total Expenses - EUR | - | 262 | 3.935 | 26.979 | 94.280 | 157.731 | 170.357 | 259.235 | 258.423 | 327.732 |
| Gross Profit/Loss - EUR | - | 7.518 | 9.123 | 2.462 | 16.676 | 70.788 | 172.829 | 161.097 | 222.818 | 268.253 |
| Net Profit/Loss - EUR | - | 7.285 | 7.948 | 2.060 | 15.566 | 68.667 | 169.707 | 156.978 | 218.102 | 226.191 |
| Employees | - | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Dermaoft Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 110 | 147.833 | 171.630 | 282.884 | 343.702 | 344.884 | 302.669 | 289.019 | 539.802 |
| Current Assets | - | 7.571 | 1.004 | 885 | 789 | 7.418 | 86.657 | 81.407 | 185.240 | 327.082 |
| Inventories | - | 0 | 9 | 0 | 0 | 4.683 | 15.643 | 16 | 6.275 | 14.884 |
| Receivables | - | 0 | 0 | 0 | 0 | 0 | 0 | 76.129 | 136.450 | 274.913 |
| Cash | - | 7.571 | 995 | 885 | 789 | 2.734 | 71.014 | 5.262 | 42.516 | 37.286 |
| Shareholders Funds | - | 7.329 | 7.992 | 9.905 | 25.357 | 93.644 | 197.611 | 157.019 | 218.142 | 226.231 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 352 | 140.845 | 162.610 | 258.315 | 255.535 | 198.166 | 173.994 | 194.644 | 376.532 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 1.444 | 35.764 | 53.064 | 61.473 | 264.122 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermaoft Medical S.r.l.